10.46
price up icon4.29%   0.43
pre-market  Pre-market:  10.80   0.34   +3.25%
loading
Fortrea Holdings Inc stock is traded at $10.46, with a volume of 1.06M. It is up +4.29% in the last 24 hours and up +24.23% over the past month. Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
See More
Previous Close:
$10.03
Open:
$10
24h Volume:
1.06M
Relative Volume:
0.69
Market Cap:
$949.77M
Revenue:
$2.98B
Net Income/Loss:
$-300.00M
P/E Ratio:
-3.0765
EPS:
-3.4
Net Cash Flow:
$225.00M
1W Performance:
-7.43%
1M Performance:
+24.23%
6M Performance:
+67.90%
1Y Performance:
-37.81%
1-Day Range:
Value
$9.72
$10.47
1-Week Range:
Value
$9.72
$11.44
52-Week Range:
Value
$3.97
$25.28

Fortrea Holdings Inc Stock (FTRE) Company Profile

Name
Name
Fortrea Holdings Inc
Name
Phone
877-495-0816
Name
Address
8 MOORE DRIVE, DURHAM
Name
Employee
14,500
Name
Twitter
Name
Next Earnings Date
2025-03-03
Name
Latest SEC Filings
Name
FTRE's Discussions on Twitter

Compare FTRE with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
FTRE
Fortrea Holdings Inc
10.46 910.72M 2.98B -300.00M 225.00M -3.40
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Fortrea Holdings Inc Stock (FTRE) Upgrades & Downgrades

Date Action Analyst Rating Change
Aug-04-25 Upgrade Robert W. Baird Neutral → Outperform
May-02-25 Initiated Truist Hold
Apr-10-25 Downgrade Barclays Equal Weight → Underweight
Dec-11-24 Downgrade Citigroup Buy → Neutral
Dec-06-24 Downgrade Robert W. Baird Outperform → Neutral
Sep-25-24 Downgrade Jefferies Buy → Hold
Aug-08-24 Downgrade Evercore ISI Outperform → In-line
Jul-24-24 Resumed Barclays Equal Weight
Jun-06-24 Initiated Goldman Neutral
May-29-24 Initiated TD Cowen Hold
May-28-24 Initiated Mizuho Neutral
Mar-22-24 Initiated Robert W. Baird Neutral
Mar-06-24 Initiated Deutsche Bank Hold
Jan-05-24 Initiated William Blair Mkt Perform
Jan-04-24 Initiated Jefferies Buy
Dec-11-23 Upgrade Citigroup Neutral → Buy
Dec-01-23 Upgrade Evercore ISI In-line → Outperform
Nov-14-23 Upgrade Barclays Equal Weight → Overweight
Oct-19-23 Initiated Citigroup Neutral
Sep-14-23 Initiated Evercore ISI In-line
Aug-16-23 Initiated Barclays Equal Weight
Aug-07-23 Initiated BofA Securities Underperform
View All

Fortrea Holdings Inc Stock (FTRE) Latest News

pulisher
07:04 AM

MUFG Securities EMEA plc Invests $2.41 Million in Fortrea Holdings Inc. $FTRE - MarketBeat

07:04 AM
pulisher
01:46 AM

Is Fortrea Holdings Inc. stock a buy before product launchesQuarterly Portfolio Review & Consistent Growth Equity Picks - newser.com

01:46 AM
pulisher
Nov 02, 2025

Advanced analytics toolkit walkthrough for Fortrea Holdings Inc.July 2025 EndofMonth & Capital Protection Trading Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why The Narrative Around Fortrea Holdings Is Shifting Amid New Analyst and Business Updates - Yahoo Finance

Nov 02, 2025
pulisher
Nov 02, 2025

How Fortrea Holdings Inc. stock performs in high volatility markets2025 Winners & Losers & Detailed Earnings Play Strategies - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Is Fortrea Holdings Inc. stock a buy for dividend growthTrade Ideas & Verified Technical Trade Signals - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Fortrea Holdings Inc. (K67) stock extend growth story2025 Fundamental Recap & AI Driven Stock Price Forecasts - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Can Fortrea Holdings Inc. (K67) stock sustain revenue momentumRate Hike & Safe Capital Growth Trade Ideas - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Will earnings trigger a reversal in Fortrea Holdings Inc.July 2025 Setups & AI Enhanced Trading Signals - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Multi asset correlation models including Fortrea Holdings Inc.Quarterly Growth Report & High Accuracy Buy Signal Tips - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Is Fortrea Holdings Inc. (K67) stock a contrarian opportunityWeekly Earnings Recap & Verified Short-Term Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Fortrea Reports Second Quarter 2025 Results - ADVFN

Oct 31, 2025
pulisher
Oct 31, 2025

Mutual of America Capital Management LLC Has $57,000 Holdings in Fortrea Holdings Inc. $FTRE - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Momentum divergence signals in Fortrea Holdings Inc. chartWeekly Gains Report & Reliable Intraday Trade Plans - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Using economic indicators to assess Fortrea Holdings Inc. potential2025 Major Catalysts & High Conviction Trade Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Fortrea Holdings Inc. (FTRE) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK

Oct 30, 2025
pulisher
Oct 30, 2025

Fortrea and GE Healthcare’s New Diagnostic Study: A Potential Game-Changer in Cancer Detection - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

Fortrea (FTRE) to Release Earnings on Wednesday - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Fortrea’s New Clinical Trial: A Game Changer in Spinal Surgery? - MSN

Oct 30, 2025
pulisher
Oct 29, 2025

Fortrea Holdings Inc. (FTRE) Stock forecasts - Yahoo! Finance UK

Oct 29, 2025
pulisher
Oct 29, 2025

Fortrea Holdings Inc. (FTRE) Stock Forecasts - Yahoo! Finance Canada

Oct 29, 2025
pulisher
Oct 29, 2025

Fortrea’s Givinostat Study: A New Hope for Young DMD Patients - TipRanks

Oct 29, 2025
pulisher
Oct 29, 2025

What drives Fortrea Holdings Inc K67 stock priceTechnical Resistance Breaks & Plan Your Exit as You Enter – Risk First - earlytimes.in

Oct 29, 2025
pulisher
Oct 29, 2025

Exploring October 2025's Top Undervalued Small Caps With Insider Activity - simplywall.st

Oct 29, 2025
pulisher
Oct 29, 2025

Fortrea Holdings Meets 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily

Oct 29, 2025
pulisher
Oct 28, 2025

Fortrea’s Givinostat Study: A Potential Game-Changer for Duchenne Muscular Dystrophy - MSN

Oct 28, 2025
pulisher
Oct 28, 2025

What Fortrea Holdings (FTRE)'s Debt Tender, Legal Scrutiny Mean for Investor Confidence - simplywall.st

Oct 28, 2025
pulisher
Oct 28, 2025

Fortrea (NASDAQ:FTRE) Shares Down 6.9% After Analyst Downgrade - MarketBeat

Oct 28, 2025
pulisher
Oct 28, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Fortrea Holdings, Inc. (FTRE) And Encourages Investors to Reach Out - ACCESS Newswire

Oct 28, 2025
pulisher
Oct 28, 2025

Fortrea Holdings, Inc. Experiences Evaluation Revision Amidst Market Dynamics and Performance Fluctuations - Markets Mojo

Oct 28, 2025
pulisher
Oct 27, 2025

Is Fortrea Holdings Inc. stock attractive for income investors2025 Support & Resistance & Verified Short-Term Plans - Fundação Cultural do Pará

Oct 27, 2025
pulisher
Oct 27, 2025

Fortrea’s Phase 1 Study on D3S-001: Evaluating Food’s Impact on Drug Absorption - TipRanks

Oct 27, 2025

Fortrea Holdings Inc Stock (FTRE) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Cap:     |  Volume (24h):